JP2005504770A - ５−スルホンアミド−８−ヒドロキシ−１，６−ナフチリジン−７−カルボキサミドの製造方法 - Google Patents

５−スルホンアミド−８−ヒドロキシ−１，６−ナフチリジン−７−カルボキサミドの製造方法 Download PDF

Info

Publication number
JP2005504770A
JP2005504770A JP2003521232A JP2003521232A JP2005504770A JP 2005504770 A JP2005504770 A JP 2005504770A JP 2003521232 A JP2003521232 A JP 2003521232A JP 2003521232 A JP2003521232 A JP 2003521232A JP 2005504770 A JP2005504770 A JP 2005504770A
Authority
JP
Japan
Prior art keywords
alkyl
compound
aryl
haloalkyl
copper
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003521232A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005504770A5 (enExample
Inventor
マリグレス，ピーター・イー
アスキン，デイビツド
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of JP2005504770A publication Critical patent/JP2005504770A/ja
Publication of JP2005504770A5 publication Critical patent/JP2005504770A5/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
JP2003521232A 2001-08-17 2002-08-13 ５−スルホンアミド−８−ヒドロキシ−１，６−ナフチリジン−７−カルボキサミドの製造方法 Withdrawn JP2005504770A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31337601P 2001-08-17 2001-08-17
PCT/US2002/027151 WO2003016309A1 (en) 2001-08-17 2002-08-13 Process for preparing 5-sulfonamido-8-hydroxy-1, 6-naphthyridine-7-carboxamides

Publications (2)

Publication Number Publication Date
JP2005504770A true JP2005504770A (ja) 2005-02-17
JP2005504770A5 JP2005504770A5 (enExample) 2006-01-05

Family

ID=23215476

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003521232A Withdrawn JP2005504770A (ja) 2001-08-17 2002-08-13 ５−スルホンアミド−８−ヒドロキシ−１，６−ナフチリジン−７−カルボキサミドの製造方法

Country Status (6)

Country Link
US (1) US20050014780A1 (enExample)
EP (1) EP1427726A1 (enExample)
JP (1) JP2005504770A (enExample)
AR (1) AR036352A1 (enExample)
CA (1) CA2456155A1 (enExample)
WO (1) WO2003016309A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002030931A2 (en) 2000-10-12 2002-04-18 Merck & Co., Inc. Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
KR101122782B1 (ko) * 2002-10-04 2012-04-12 프라나 바이오테크놀로지 리미티드 신경 활성 화합물
WO2005028478A1 (en) 2003-09-19 2005-03-31 Gilead Sciences, Inc. Aza-quinolinol phosphonate integrase inhibitor compounds
WO2006125048A2 (en) * 2005-05-16 2006-11-23 Gilead Sciences, Inc. Hiv-integrase inhibitor compounds
BRPI0710737A2 (pt) 2006-04-14 2011-05-10 Prana Biotechnology Ltd uso de compostos pb-10 33 éteis para o tratamento de degeneraÇço macular relacionada À idade (amd), assim como referidos compostos
EP3313420B1 (en) 2015-06-25 2024-03-13 The Children's Medical Center Corporation Methods and compositions relating to hematopoietic stem cell expansion, enrichment, and maintenance
DK3429603T3 (da) 2016-03-15 2022-03-14 Childrens Medical Center Fremgangsmåder og sammensætninger vedrørende ekspansion af hæmatopoietiske stamceller
CA3237199A1 (en) 2021-11-02 2023-05-11 Flare Therapeutics Inc. Pparg inverse agonists and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH214351A (de) * 1938-08-30 1941-04-15 Cilag Chemisches Ind Lab A G Verfahren zur Darstellung eines Derivates des 2-Aminopyridins.
WO2002030931A2 (en) * 2000-10-12 2002-04-18 Merck & Co., Inc. Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors

Also Published As

Publication number Publication date
WO2003016309A1 (en) 2003-02-27
US20050014780A1 (en) 2005-01-20
AR036352A1 (es) 2004-09-01
EP1427726A1 (en) 2004-06-16
CA2456155A1 (en) 2003-02-27

Similar Documents

Publication Publication Date Title
CN113527272B (zh) 一种特戈拉赞的合成方法
TWI510451B (zh) 具有ｈｉｖ接合酶抑制活性的化合物之製造方法
US6444820B1 (en) Process for the manufacture of camptothecin derivatives
JP4252797B2 (ja) Ｈｉｖインテグラーゼ阻害薬として有用なアザ−およびポリアザ−ナフタレニルカルボキサミド類
JP4287649B2 (ja) Ｈｉｖインテグラーゼ阻害薬として有用なアザ−およびポリアザ−ナフタレニルカルボキサミド類
RU2728829C1 (ru) Новое изоиндолиновое производное, включающая его фармацевтическая композиция и его применение
AU2003220170B2 (en) N-(Substituted benzyl)-8-hydroxy-1,6-naphthyridine-7- carboxamides useful as HIV integrase inhibitors
WO2010096722A1 (en) 3-oxo-2, 3-dihydro- [1,2, 4] triazolo [4, 3-a]pyridines as soluble epoxide hydrolase (seh) inhibitors
JP2005504770A (ja) ５−スルホンアミド−８−ヒドロキシ−１，６−ナフチリジン−７−カルボキサミドの製造方法
CN105693746A (zh) 噁唑烷酮类化合物的制备方法及其中间体
TW200530233A (en) Process for the preparation of CCR-2 antagonist
TWI725710B (zh) 3-溴-5-(2-乙基咪唑並[1,2-a]吡啶-3-羰基)-2-羥基苯甲腈的合成
EP2982673B1 (en) Process for manufacturing 5-chloromethyl-2,3-dicarboxylic anhydride
AU2004303515A1 (en) Aminopyridine-derivatives as inductible no-synthase inhibitors
US7109353B2 (en) Process for preparing 5,6-dihydro-4-(S)-(ethylamino)-6-(S) methyl-4H-thieno[2,3b]thiopyran-2-sulphonamide-7,7-dioxide HCl
AU2002327535A1 (en) Process for preparing 5-sulfonamido-8-hydroxy-1, 6-naphthyridine-7-carboxamides
US20040186093A1 (en) Process for preparing sultams
TWI391380B (zh) 製備苯并咪唑化合物之方法
TWI389912B (zh) 用於製備ｎ－〔５－（３－二甲胺基－丙烯醯基）－２－氟苯基〕－ｎ－甲基－乙醯胺之方法
JP7617845B2 (ja) （６Ｓ）－３－［（４Ｓ）－４－シアノ－２－オキソ－ピロリジン－１－イル］－６－メチル－Ｎ－（３，４，５－トリフルオロフェニル）－６，７－ジヒドロ－４Ｈ－ピラゾロ［１，５－ａ］ピラジン－５－カルボキサミドの調製のための方法
HK40090878A (zh) 用於制备1-甲基-6-[6-r2-5-甲基-8-(甲基氨基)-4-[(3as，6as)-5-甲基-2，3，3a，4，6，6a-六氢吡咯并[2，3-c]吡咯-1-基]-9h-吡啶并[2，3-b]吲哚-3-基]-4-氧代-1，8-萘啶-3-甲酸盐酸盐的方法
TW201534607A (zh) 製備經取代的［１，２，４］三唑并［１，５－ａ］吡啶化物之方法
HK40008858B (zh) 一种新的异二氢吲哚衍生物、其药物组合物及应用
JPH1053586A (ja) ９−ヒドロキシエリプチシンの製法
JPH08198851A (ja) メチルアミノピリジン誘導体の合成方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050801

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050801

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20050825